ABSTRACT-The gut is a continuously renewing organ, with cell proliferation, migration, and death occurring rapidly under basal conditions. As the impact of critical illness on cell movement from crypt base to villus tip is poorly understood, the purpose of this study was to determine how sepsis alters enterocyte migration. Wild-type, transgenic, and knockout mice were injected with 5-bromo-2'deoxyuridine (BrdU) to label cells in S-phase before and after the onset of cecal ligation and puncture and were sacrificed at predetermined endpoints to determine distance proliferating cells migrated up the cryptvillus unit. Enterocyte migration rate was decreased from 24 to 96 h after sepsis. BrdU was not detectable on villi 6 days after sham laparotomy, meaning all cells had migrated the length of the gut and been exfoliated into its lumen. However, BrdU positive cells were detectable on villi 10 days after sepsis. Multiple components of gut integrity altered enterocyte migration. Sepsis decreased crypt proliferation, which further slowed enterocyte transit as mice injected with BrdU after the onset of sepsis (decreased proliferation) had slower migration than mice injected with BrdU before the onset of sepsis (normal proliferation). Decreasing intestinal apoptosis via gut-specific overexpression of Bcl-2 prevented sepsis-induced slowing of enterocyte migration. In contrast, worsened intestinal hyperpermeability by genetic deletion of JAM-A increased enterocyte migration. Sepsis therefore significantly slows enterocyte migration, and intestinal proliferation, apoptosis and permeability all affect migration time, which can potentially be targeted both genetically and pharmacologically.
INTRODUCTION
Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection (1) . Although multiple components of the host response have been implicated in mortality from sepsis, the gut has long been hypothesized to be the motor of multiple organ dysfunction syndrome (2) (3) (4) (5) . Multiple components of gut integrity are dysregulated during sepsis, including decreased proliferation, increased apoptosis, decreased villus length, increased intestinal permeability, and loss of microbiome diversity with increased virulence (6) (7) (8) (9) .
The gut epithelium is made up of only a single layer of columnar cells that are continuously renewed from multipotent stem cells originating in the crypt (10) . The number of gut epithelial cells available to perform the critical work of the intestine is dependent on the relationship between cell production, migration, and loss. Proliferating cells are restricted to the Crypts of Lieberkühn. As intestinal epithelial cells migrate up the crypt to the villus, they differentiate into absorptive enterocytes, mucus-producing goblet cells, and hormone-producing enteroendocrine cells. Cells that migrate to the villus tip either die by apoptosis or are exfoliated whole into the lumen. The entire journey of cell production, migration, and differentiation and then loss takes less than a week.
Cell migration is a highly integrated multistep process, including cellular protrusions, establishment, and reconfiguration of cell matrix adhesions and intercellular contacts (11) . Although incompletely understood, migration is controlled by a complex array of signaling pathways, and under basal conditions, intestinal epithelial cell migration is impacted by gut proliferation, apoptosis, and permeability (12) (13) (14) (15) (16) . In addition, FAK and its phosphorylated form P-FAK regulate cell migration and adhesion (17) , and TLR4 signaling has been demonstrated to increase phosphorylation of FAK and alter intestinal epithelial migration in murine necrotizing enterocolitis (18, 19) . Further, enterocyte migration has been demonstrated to be decreased at 24 and 48 h after CLP (no earlier or later time points have previously been examined), associated with a decrease in milk fat globule-EGF 8 (20) . In light of the gut's role in perpetuating sepsis and the relative paucity of data on intestinal epithelial migration in sepsis, the aim of this study was to obtain a more comprehensive understanding of how sepsis alters enterocyte migration and whether targeting gut integrity would, in turn, change intestinal migration.
MATERIALS AND METHODS

Mice
Six-to 10-week old male and female wild-type (WT) C57Bl/6 mice and TLR2
À/À mice were purchased from Jackson Laboratory (Bar Harbor, Maine) as were C3H/HeJ and C3H/HeOuJ (WT controls for C3H/HeJ) mice. Mice that mice were 6-to 10-week old and sex matched. All transgenic and knockout mice were compared with WT mice on the same genetic background (i.e., Bcl-2 transgenic mice were compared with WT FVB/N mice and JAM-A À/À mice and TLR2 À/À mice were compared with WT C57Bl/6 mice). Mice were kept on a 12-h light-dark cycle in a dedicated facility managed by the Emory University Division of Animal Resources and received water and mouse chow ad libitum throughout. All experiments were performed in accordance with the National Institutes of Health Guidelines for the Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at Emory University School of Medicine (Protocol DAR-2002717-042217GN).
Sepsis model
Polymicrobial sepsis was induced via cecal ligation and puncture (CLP) (23) . Animals were anesthetized with isoflurane, and a small midline abdominal incision was made. The cecum was ligated immediately distal to the ileocecal valve and punctured twice with a 21-gauge needle, gently squeezed to extrude a small amount of stool, and replaced in the abdomen which was closed in layers. Sham mice were treated identically with the exception that the cecum was neither ligated nor punctured. To minimize animal suffering, animals received buprenex (0.1 m/kg; McKesson Medical, San Francisco, Calif) immediately preoperatively. To mimic the treatment of septic patients (24) , all mice received antibiotics (Ceftriaxone 50 mg/kg: Sigma, St. Louis, Mo; Metronidazole, 30 mg/kg: Apotex Corp, Weston, Fla) every 12 h for 2 days after the onset of sepsis as well as fluid resuscitation (1 mL normal saline) postoperatively.
Crypt proliferation
Mice received intraperitoneal injection of the thymidine analogue BrdU (50 mg/kg, diluted in 0.9% saline; Sigma) to label cells in S-phase. BrdU was detected in jejunal sections via immunohistochemistry. Sections were deparaffinized, rehydrated, incubated in hydrogen peroxide, placed in Antigen Decloaker, and then heated in a pressure cooker. Sections were blocked for 30 min with Protein Block (Dako, Carpinteria, Calif) and then incubated with rat monoclonal anti-BrdU (1:500; Accurate Chemical & Scientific, Westbury, NY) overnight at 4 o C. The following day, sections were incubated at room temperature with goat anti-rat secondary antibody (1:500; Accurate Chemical & Scientific), followed by streptavidin-horseradish peroxidase (1:500; Dako). Sections were developed with diaminobenzidine, followed by counterstaining with hematoxylin. Proliferation was assessed by quantifying BrdU positive cells in 100 crypts of well-oriented jejunal crypt-villus units in a blinded fashion.
Villus length
Villus length was measured from the crypt neck to the villus tip on H&E-stained slides in micrometers (Nikon Instruments, Melville, NY). A minimum of 12 well-oriented jejunal villi from each section were measured in a blinded fashion.
Migration
Migration distance was measured as the distance from crypt neck to foremost BrdU positive enterocyte in micrometers. Migration rate was measured as migration distance divided by time in hours between BrdU injection and sacrifice in 12 well-oriented jejunal crypt-villus units using MetaMorph Version 7.1.2.0 (Downingtown, Pa). Migration distance as a fraction of villus length was evaluated by measuring the distance from crypt base to the foremost BrdU labeled enterocyte divided by the distance from the crypt base to the villus tip. All measurements were performed in blinded fashion.
Real-time polymerase chain reaction
Total RNA was isolated from frozen jejunal tissue using the RNeasy Mini Kit (Qiagen, Santa Clarita, Calif) according to the manufacturer's protocol. After this, cDNA was synthesized from 2 mg of total RNA. CD31/PECAM-1 mRNA levels were detected using predeveloped TaqMan primers and probes (Applied Biosystems, Foster, Calif) and run on the StepOnePlus Real-Time PCR System (Applied Biosystems). Samples were run in duplicate and normalized to expression of GAPDH (Applied Biosystems). Relative quantification of PCR products were based upon the value differences between the target gene and GAPDH using the comparative CT method.
Kinase inhibitor
Mice received an intraperitoneal injection of either the cell-permeable, selective FAK inhibitor, 1,2,4,5-Benzenetetraamine tetrahydrochloride (FAK Inhibitor 14, Y15, 30 mg/kg; Sigma) or vehicle 12 h after CLP.
Statistical analysis
Data are presented as mean AE SEM. Data were tested for normality using the D'Agostino-Pearson omnibus normality test. Two-way comparisons were performed using the Student t test if data were found to have a Gaussian distribution. Alternatively, if data did not have a Gaussian distribution, comparisons were performed using the Mann-Whitney test. Comparisons with three or more groups were performed using one-way ANOVA followed by Sidak posttest. All data were analyzed using the statistical software program Prism 6.0 (GraphPad Software, San Diego, Calif), and a P < 0.05 was considered to be statistically significant.
RESULTS
Sepsis significantly slows intestinal epithelial migration and migration distance as fraction of villus length
BrdU was injected in animals immediately before CLP or sham surgery, and animals were sacrificed at time points from 6 to 96 h later. As BrdU labels cells in S-phase at time of injection, this experiment was designed to measure the impact of sepsis on how far crypt epithelial cells migrated up the villus between time of injection and time of sacrifice. There were no detectable differences in the distance cells migrated in the first 6 h after CLP compared with sham surgery. However, a significant difference in how far crypt cells migrated up the villus was apparent as early as 24 h after the onset of sepsis with crypt cells migrating a smaller distance after CLP. This difference persisted for 96 h (Fig. 1, A 
and B).
Although migration rate is important for understanding how far crypt cells migrate over a fixed length of time, villus length is decreased after sepsis due to a complex interplay of altered proliferation, migration, and apoptosis (25) . Thus migration rate (distance traveled/hours traveled) fails to account for the relative difference in villus length. As such, migration distance as a fraction of villus length was also evaluated. Sepsis markedly slowed migration distance as a fraction of villus length from 24 to 96 h after CLP (Fig. 1C) .
Based upon differences between sham and septic mice at 96 h (Fig. 1) , a different group of animals were followed to determine how long BrdU positive cells were detectable on the villus. In sham animals, BrdU was no longer detectable on the villus 6 days after CLP, meaning all cells had migrated and been exfoliated into the gut lumen by this time in sham operated mice. In contrast, BrdU positive cells were detectable on the villus until 10 days after CLP, suggesting it takes nearly twice as long for crypt epithelial cells to complete their migration up the villus after sepsis than under basal conditions (Supplementary Fig. 1 , http://links.lww.com/SHK/A699).
Sepsis decreases crypt proliferation for 4 days after CLP
To determine whether a minor inflammatory insult impacted crypt proliferation, animals were injected with BrdU 24 h after sham laparotomy and compared with unmanipulated mice injected with BrdU. Crypt proliferation was similar between sham mice and unmanipulated mice (data not shown). Next, animals were made septic and sacrificed 24 to 120 h after sepsis. BrdU was injected in animals 90 min before sacrifice to determine how the length of time an animal was septic altered crypt proliferation. Proliferation was decreased 24 h after CLP (Fig. 2, A and B) , and proliferation continued to decrease with each 24 h increment after sepsis with the greatest decrease noted 72 h after CLP. Proliferation began to recover at 96 h, but did not return to baseline levels until 120 h after CLP.
Sepsis decreases villus length for 8 days after CLP
Villus length was compared 6 h to 9 days after either sham laparotomy or CLP. Villus length was shorter 6 h after CLP and remained shorter in septic mice out to 8 days (although no difference was seen at 7 days). Villus length returned to basal levels by 9 days (Fig. 3A) .
Sepsis decreases the number of epithelial cells per villus for 8 days after CLP
The total number of cells per villus is potentially impacted by crypt proliferation, rate of cell migration up the crypt and villus, crypt and villus apoptosis, and cell-cell interaction and intrinsic cellular properties. As elements of gut integrity after sepsis might be expected to have opposing influences on the number of cells/villus (decreased proliferation potentially decreasing the number of cells with decreased migration rate potentially increasing the number of cells), it was unclear whether shorter villi were due to fewer cells or increased cell density within the villus. As such, the total number of cells/villus was compared between sham and septic mice. The number of cells/villus decreased out to 8 days (although no difference was seen at 7 days), and returned to basal levels at day 9 (Fig. 3B) , directly mirroring villus length (Fig. 3A) . Overall villus cell density was similar between sham and septic mice (Supplemental Fig. 2A , http://links.lww.com/SHK/A700). However, villus cell density was not uniform with cell density being markedly higher in the bottom third of the villus than the middle or top third in both sham and septic mice (Supplemental Fig. 2 , B and C, http:// links.lww.com/SHK/A700). No differences in cell density were noted in any of the regions of the villus between sham and FIG. 1. Intestinal epithelial migration is decreased after sepsis. Although no difference was detected at 6 h (P ¼ 0.19), migration was slower at 24 (P ¼ 0.0001), 48 (P ¼ 0.001), 72 (P < 0.0001), and 96 h (P < 0.0001) after sepsis (A, n ¼ 8-9/group for each time point). Representative histomicrographs are shown for each time point (B, BrdU stains brown). Migration as a fraction of villus length (measured since villus length is decreased after sepsis) was also not different at 6 h (P ¼ 0.19), but was decreased at 24 (P ¼ 0.003), 48 (P ¼ 0.004), 72 (P < 0.0001), and 96 h (P ¼ 0.0002) after sepsis (C, n ¼ 8-9/group for each time point).
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Sepsis-induced decreases in proliferation slow intestinal epithelial migration
Animals were next injected with BrdU either before the onset of sepsis or 24 h after CLP and sacrificed 24, 48, or 72 h after labeling with BrdU. This experimental design allowed cells to migrate for the same length of time after BrdU injection; however, it allowed for examination of the importance of crypt proliferation on migration because animals injected with BrdU before the onset of sepsis had normal crypt proliferation when S-phase cells were labeled, whereas animals injected with BrdU 24 h after the onset of sepsis had decreased crypt proliferation when S-phase cells were labeled. Migration was slower in mice with sepsis-induced reductions in proliferation 24, 48, and 72 h after injection of BrdU than those with normal proliferation before the injection of BrdU (Fig. 4, A and B) . As villus length is decreased after sepsis, migration distance as a fraction of villus length was also calculated. Migration distance as a fraction of villus length was slower in mice with decreased proliferation at time of BrdU injection (Fig. 4C) .
As proliferation is further decreased 48 h after sepsis (Fig. 2) , a different cohort of mice was also injected with BrdU 48 h after the onset of sepsis (when crypt proliferation was further decreased when S-phase cells were labeled) and compared with mice injected with BrdU before the onset of sepsis. Animals were then sacrificed 24, 48, or 72 h after labeling cells in S-phase (i.e., 24, 48, or 72 h after CLP in the former group; 72, 96, 120 h after CLP in the latter group, with cells allowed to migrate for the identical length of time because BrdU was injected 48 h later in the latter group). Migration was slower in the cohort of mice with decreased sepsis-induced proliferation 24 and 48 h (but not 72 h) after injection of BrdU than those with normal proliferation (data not shown). Migration distance as a fraction of villus length was slower in mice with decreased proliferation at time of BrdU injection at 24 h but not at later time points (data not shown).
FIG. 2.
Crypt proliferation is decreased after sepsis. The number of S-phase cells in the crypt decreased at 24 (P ¼ 0.001), 48 (P ¼ 0.0002), 72 (P < 0.0001), and 96 h (P ¼ 0.003), but returned to baseline 120 h (P ¼ 0.23) after sepsis (A, n ¼ 21-28/group for each time point). Representative histomicrographs are shown for each time point (B, BrdU stains brown).
Prevention of sepsis-induced apoptosis prevents sepsisinduced slowing of intestinal epithelial migration
To determine the importance of intestinal epithelial apoptosis on migration, mice with intestine-specific overexpression of the antiapoptotic protein Bcl-2 (which we have previously shown have a marked decrease in sepsis-induced gut apoptosis (21) ) and WT mice were examined. Of note, both groups of animals were on an FVB/N genetic background. Both groups of animals received BrdU 90 min before sham laparotomy or CLP and were then sacrificed at 48 h. In contrast to WT mice that showed a significant decrease in migration at 48 h, there was no difference in migration distance 48 h after the onset of sepsis in Bcl-2 mice (Fig. 5, A and B) .
Sepsis-induced intestinal hyperpermeability increases intestinal epithelial migration
To determine the importance of intestinal permeability on migration, migration was examined in septic JAM-A À/À mice (which have increased intestinal permeability) (22) by injecting BrdU 90 min before sham laparotomy or CLP. JAM-A À/À mice had a significant increase in migration rate (Fig. 5, C and D) .
Blocking FAK and deletion of TLR4 leads to further slowing of enterocyte migration after CLP In light of data suggesting FAK and P-FAK play a role in enterocyte migration (18, (26) (27) (28) , Y15, a P-FAK inhibitor, was given 12 h after CLP and mice were sacrificed 48 h after sepsis. Mice given Y15 had a marked decrease in enterocyte migration rate (significantly slower than the already slowed decrease in migration induced by sepsis in isolation; Fig. 6A ). Migration was also slower in C3H/HeJ mice (that have a mutation in TLR4 making them resistant to LPS) compared with WT mice (Fig. 6B) . In contrast, migration was unaffected in TLR2 À/À mice (Fig. 6C) . In addition, jejunal CD31/PECAM-1 mRNA levels were unaffected by sepsis (Fig. 6D) .
DISCUSSION
The surface area available for the intestinal epithelium to perform its vital functions is controlled by a delicate balance between crypt proliferation, cell migration, and cell loss. Each of these processes is markedly altered in sepsis, and although gut proliferation and apoptosis have been extensively studied in sepsis, much less was previously known about migration. Herein we show that migration rate and migration distance as a fraction of villus length are markedly decreased in sepsis. Furthermore, alterations in multiple components of gut integrity impact intestinal migration.
Most alterations in gut integrity after sepsis are more transient than the lengthy decrease in migration. Gut apoptosis peaks at 24 h after CLP and then begins to normalize within 2 days (29) . Similarly, gut permeability rapidly increases after the onset of sepsis, peaks at 6 to 12 h and begins to decrease 24 to 48 h after CLP (6) . Proliferation is also decreased for 4 days after CLP (Fig. 2 ) but returns to normal thereafter. In contrast, migration is decreased after sepsis for a longer period of time, and it takes nearly twice as long for a crypt cell to migrate up the length of the villus in a septic mouse as in a sham animal.
The relationship between cellular proliferation and migration is complex, and many assays have difficulty uncoupling
Villus length is decreased after sepsis. The length from the villus base to tip was decreased as early as 6 h and was decreased 1, 2, 3, 4, 5, 6, and 8 days after CLP. Villus length was similar in sham and septic mice at 7 days and returned to baseline at 9 days (A, n ¼ 10/group for each time point). Similar findings were obtained when quantifying the number of cells/villus (B).
these processes (30) , to the point that attempts to examine a pure migration response are often made with simultaneous inhibition of cellular proliferation (31) . Migration has been demonstrated to be associated with proliferation in the small intestine, as mice with a genetic deletion of cystic fibrosis transmembrane conductance regulator have increased migration rates and proliferation without a change in apoptosis (32) . To understand the relationship between proliferation and migration, we took advantage of the fact that sepsis decreases proliferation. As BrdU rapidly intercalates into S-phase cells, BrdU injected just before sepsis labeled cells with normal proliferation, whereas BrdU injected after the onset of sepsis labeled cells with decreased proliferation. Allowing BrdU to migrate for the identical length of time in all animals allowed us to see how proliferation impacted migration and allows us to conclude that decreased proliferation results in a further diminution in migration than sepsis alone.
The relationship between migration and apoptosis is tissue specific. Under basal conditions, inactivation of intestine-specific caspase 8 diminishes migration of enterocytes (33) . As inactivation of a proapoptotic (and necroptotic) mediator slows migration, we examined what would happen if we diminished apoptosis (but not necrosis) in sepsis. In contrast to basal conditions, prevention of sepsis-induced apoptosis via gutspecific overexpression of Bcl-2 resulted in normalized intestinal epithelial migration as there were no differences between sham and septic transgenic mice in migration rate. Similarly, under basal conditions, permeability is associated with alterations in intestinal migration (15, 16) . As such, migration was examined in septic JAM-A À/À mice. The finding of increased rates of migration in septic JAM-A À/À mice suggests that permeability may alter migration based upon the fact that these animals have sepsis-induced hyperpermeability from deletion of a critical tight junction-associated protein. Alternatively, as JAM-A À/À mice have chronic hyperpermeability at baseline (22) and have an altered microbiome at baseline (unpublished observations), the microbiome and/or the host response to chronic leakage of bacteria may play a role in migration, especially in light of observations that germ-free mice have markedly attenuated migration up the crypt-villus axis (34) .
To examine potential mechanisms responsible for decreased migration in sepsis, FAK was examined because this protein and its phosphorylated form P-FAK are critical components that regulate cell migration and adhesion (17) . We administered the inhibitor Y15. Inhibition resulted in a further slowing of enterocyte migration after CLP, suggesting that P-FAK is not responsible for the slowed migration in sepsis as we would have expected an increase in migration rate with inhibition had this been the case. The role of FAK and P-FAK in cell migration is conflicting (18, (26) (27) (28) , and our results are consistent with a tissue-specific, insult-specific role. Notably, TLR4 signaling has been demonstrated to increase phosphorylation of FAK and alter intestinal epithelial migration in part via induction of autophagy in a murine model of necrotizing enterocolitis (18, 19) . Based upon this, we examined C3H/HeJ mice that have a mutation in TLR4 making them resistant to LPS and found that migration was slower than in WT C3H/HeOuJ mice. This is the opposite of what was found in necrotizing enterocolitis where migration was more rapid in diseased animals that lacked TLR4. We do not have a clear explanation for this difference beyond obvious distinctions in age (4-day-old mice vs. 6-10-week-old mice) and illness model. In addition, our findings are consistent with a previous study by Bu et al. which demonstrated that migration is decreased at 24 and 48 h after CLP (no other time points were examined) (20) . We believe our findings should be viewed as complementary because none of the other multiple endpoints examined in this study were looked at in the Bu et al. study, which focused on milk fat globule-EGF 8. Notably, a subsequent study by this same group demonstrated that an anti-miR99b spherical nucleic acid nanoparticle conjugate enhanced milk fat globule-EFG 8, and this attenuated decreases in migration caused by lipopolysaccharide (35) .
This study has several limitations. First, the study cannot determine whether slowed migration is adaptive or maladaptive. On the surface, it seems like decreased migration represents an adaptive response to decreased proliferation and increased death because it leaves more cells to do the critical work of the intestine. This is because villi would theoretically be even shorter if migration was not slowed by sepsis. However, the presence of cells is not equivalent to the functionality of those cells and our experimental design cannot determine whether slowed intestinal migration alters cellular function. Next, the villus is cylindrical, with cells migrating to multiple villi from a single crypt and villi, in turn, receiving cells from multiple crypts. Although histology is a commonly used approach for studying gut migration, it results in a two-dimensional representation of a three-dimensional process, and there may be nuances of migration that were not captured with this loss of dimensionality. Next, we studied only a single geographic region of the intestine (the jejunum). This was picked because it is the area with maximal changes in apoptosis and permeability. However, there are likely regional differences in migration that were missed by this experimental design. In addition, we examined transgenic and knockout mice and inhibitor studies at only one time point, whereas migration is altered for many days after the onset of sepsis, and it is possible that if we had looked earlier or later, we would have seen changes in migration that were not detected by only examining mice at a single time point. Finally, we used only a single stain (BrdU) to examine proliferating and migrating cells. Although there are multiple publications using BrdU only to identify proliferating cells and to examine cell migration, other markers of proliferation including PCNA and Ki-67 could have been used to verify our results.
Despite these limitations, this study yields new insights into how sepsis alters intestinal migration and how other components of intestinal integrity modulate migration. Further work needs to be done to determine the molecular mechanisms underlying these alterations in migration.
